Source: International Congress 2017 – Asthma management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Bhattacharyya (Delhi (New Delhi), India). Three years follow up after injection omalizumab therapy. 3974

Member's Comments

No comment yet.

Related content which might interest you: Severe asthma outcomes over two years of therapy with mepolizumab Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Outcomes over the first two years of treatment with mepolizumab in severe asthma Source: Eur Respir J, 58 (6) 2101313; 10.1183/13993003.01313-2021 Year: 2021 The oral corticosteroid sparing effect of omalizumab in patients with severe chronic asthma: Is there a difference when you become 12 years old? Source: Annual Congress 2011 - Treating childhood asthma Year: 2011 A comparison of nebulized budesonide, intramuscular and oral dexamethasone in the treatment of croup among children aged 6-36 months Source: Eur Respir J 2003; 22: Suppl. 45, 284s Year: 2003 Does daily SMS increase adherence to asthma treatment? A three months follow-up study Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009 The effect of single dose inhaled budesonide on Amppc20 in patients with mild asthma: a 3 month follow up Source: Eur Respir J 2005; 26: Suppl. 49, 369s Year: 2005 Growth deceleration of children on inhaled corticosteroids is compensated for after the first 12 months of treatment Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007 Asthma control and medication use five years after early or delayed introduction of inhaled corticosteroids in asthma Source: Eur Respir J 2003; 22: Suppl. 45, 34s Year: 2003 Decreasing dose protocol for omalizumab treatment in oral corticosteroid allergic asthma patients Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E Year: 2011 Less than 20% of COPD patients persist with long-acting inhaled drugs for at least three years Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 The success of CPAP therapy in patients over 70 years Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 Six months and one year follow up of COPD patients who had oral nutritional supplement therapy as a part of pulmonary rehabilitation program Source: Annual Congress 2012 - The latest insights in pulmonary rehabilitation Year: 2012 Response to mepolizumab treatment is sustained across 4-weekly dosing periods Source: ERJ Open Res, 6 (3) 00068-2020; 10.1183/23120541.00068-2020 Year: 2020 The treatment with flunisolide in severe steroid asthmatics: the three-year follow-up study Source: Eur Respir J 2001; 18: Suppl. 33, 47s Year: 2001 The efficacy of omalizumab in severe in asthma after treatment withdrawal Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Does adherence to ICS/LABA therapy affect response to mepolizumab in the treatment of severe asthma? Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Long-term follow-up of patients under omalizumab initiated during the pre-approval period in France Source: Annual Congress 2010 - Management of airway disease Year: 2010 The use of high-dose inhaled corticosteroids and add-on therapy in children in the UK: an observational study of 4332 patients Source: Annual Congress 2004 - New aspects of drug therapy in paediatric asthma Year: 2004 Severe asthma and biologic therapies during COVID-19: supporting patients care with home administration of mepolizumab and omalizumab Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 Follow-up results 10 years after early intervention with budesonide or terbutaline in mild persistent asthma Source: Eur Respir J 2006; 28: Suppl. 50, 667s Year: 2006